The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of Exelixis Inc (NASDAQ: EXEL) was $36.94 for the day, down -16.78% from the previous closing price of $44.39. In other words, the price has decreased by -$16.78 from its previous closing price. On the day, 15.73 million shares were traded. EXEL stock price reached its highest trading level at $38.445 during the session, while it also had its lowest trading level at $36.8125.
Ratios:
Our analysis of EXEL’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 15.11 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.85. For the most recent quarter (mrq), Quick Ratio is recorded 3.44 and its Current Ratio is at 3.51. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, RBC Capital Mkts on July 08, 2025, Downgraded its rating to Sector Perform and sets its target price to $50 from $45 previously.
On June 24, 2025, Stephens Upgraded its rating to Overweight which previously was Equal-Weight but kept the price unchanged to $60.
Wells Fargo Downgraded its Overweight to Equal Weight on February 24, 2025, while the target price for the stock was maintained at $36.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 02 ’25 when Eckhardt Sue Gail sold 18,838 shares for $42.74 per share. The transaction valued at 805,140 led to the insider holds 21,380 shares of the business.
WYSZOMIERSKI JACK L sold 7,535 shares of EXEL for $324,683 on Jun 03 ’25. The Director now owns 358,882 shares after completing the transaction at $43.09 per share. On Jun 03 ’25, another insider, JACK L WYSZOMIERSKI, who serves as the Director of the company, bought 7,535 shares for $43.09 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EXEL now has a Market Capitalization of 9944358912 and an Enterprise Value of 9333085184. As of this moment, Exelixis’s Price-to-Earnings (P/E) ratio for their current fiscal year is 17.72, and their Forward P/E ratio for the next fiscal year is 11.48. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.53. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.36 while its Price-to-Book (P/B) ratio in mrq is 4.91. Its current Enterprise Value per Revenue stands at 4.185 whereas that against EBITDA is 11.942.
Stock Price History:
The Beta on a monthly basis for EXEL is 0.30, which has changed by 0.5752665 over the last 52 weeks, in comparison to a change of 0.15366066 over the same period for the S&P500. Over the past 52 weeks, EXEL has reached a high of $49.62, while it has fallen to a 52-week low of $22.96. The 50-Day Moving Average of the stock is -14.93%, while the 200-Day Moving Average is calculated to be -0.44%.
Shares Statistics:
EXEL traded an average of 3.37M shares per day over the past three months and 4019550 shares per day over the past ten days. A total of 270.13M shares are outstanding, with a floating share count of 263.97M. Insiders hold about 3.20% of the company’s shares, while institutions hold 92.86% stake in the company. Shares short for EXEL as of 1752537600 were 18267722 with a Short Ratio of 5.43, compared to 1749772800 on 20385497. Therefore, it implies a Short% of Shares Outstanding of 18267722 and a Short% of Float of 9.19.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
